KYLE WHITE: Open Payments
NPI 1922768860 · LA MESA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,473 in 39 payments from 12 companies in 2025. Trend: 2023 $102 · 2024 $224 · 2025 $1,473
Food & beverage: $1,405Education: $67
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 8 | $443 |
| GlaxoSmithKline, LLC. | 16 | $345 |
| AstraZeneca Pharmaceuticals LP | 3 | $255 |
| PFIZER INC. | 1 | $92 |
| Stryker Corporation | 2 | $79 |
| Resmed Corp | 1 | $67 |
| Optinose US, Inc. | 2 | $52 |
| Smith+Nephew, Inc. | 2 | $47 |
| ABBVIE INC. | 1 | $33 |
| Paratek Pharmaceuticals, Inc. | 1 | $25 |
Products named: DUPIXENT, NUCALA, TEZSPIRE, NURTEC ODT, Xhance, AIRSENSE, LATERA, XPRESS LOPROFILE.
Industry payments across CA — which companies pay providers there.
